22-11-22 Ricu

DATE
BED 1 DAY OF CARE
IDENTITY+A3:I44
SEX PR
NAME Yuliarti
DIAGNOSIS
53thn
AGE
MR 01095408 GCS
DATE IN 21-11-22 TD
VIT
DPJP AL HR
1. dr.Kurniaji, Sp. An RR
SIG
2. SPO2
N
TEMP
ANAMNESIS
penurunan kesadaran sejak 1 PH
PCO2
hari SMRS, awalnya muntah
3x, demam (-) batuk (-) sesak PO2
(-) AGD HCO3
RPD : Riwayat covid-19/mei TCO2
2022 BE
Riwayat gangguan irama SaO2
jantung (+) GDS
Riwayat hipertensi : amlodipin Na
1x10mg, candesartan 1x16mg ELE
DIAGNOSIS CTR K
Susp.COVID-19 Derajat Berat
Penurunan kesadaran ec stroke OLY Ca
infark dd SOL TE Lactat
CAP OXYGEN
HHD INPUT
VES
VES OUTPUT
Hiponatremia
IWL
Hipertensi
NOTES BALANCE
URINE
OUTPUT
(cc/kgbb/jam)
THERAPY
Fluid / Food
Analgetic
Sedation
Thromboemboli
cHead
prophylaxis
of bed
elevtation
Ulcer (stress)
prophylaxis
Glycemic
control
Spontaneous
Breathing Trial
Indwelling
Bowel Care
Catheter
Removal
De-escalation of
antibiotics
SUBJECTIVE
PHYSICAL EXAMI
PLANNING
NOTES
LABORATORIUM
Hemoglobin
Leukosit
Trombosit
Hematokrit
PT
INR
APTT
SGOT
SGPT
Ureum
Creatinin
Albumin
D-dimer
CRP
Ferritin
Anti HIV
HbsAg
Anti HCV
Total Bil
Bil Indirek
Bil Direk
IL-6
LDH
Anti SARS-COV2 IgG
Anti SARS-COV2 IgM
Urinalisa
Blood Culture
Urine Culture
Sputum Culture
Procalcitonin
Date
Swab
Result
Support
Date
21-11-22

Penurunan kesadaran ec stroke infark dd
SOL
CAP
HHD
VES
Hiponatremia
Hipertensi
E3M4Vafasia
159/86
67
18
100
36,7
7,448
34,4
189
23,8
25
0
100
128
127
4,5
1,21
NK 3LPM
640
100
127
+413
0,3
IVFD Nacl 0.9% 40cc/jam

IVFD Nacl 3% 20cc/jam
Head Up 30
Lansoprazole 1x30mg IV
Resfar 1x2.5 gr IV
Dexamethason 3x5mg IV
Ceftriaxone 1x2 gr IV
Vit C 3x400mg IV
Furosemide 2x20mg IV
Vit D 1x5000iu PO
Azitromicin 1x500mg PO
Candesartan 1x16mg PO
Bisoprolol 1x2.5mg PO
Amlodipin 1x5mg PO
21-11-22
11,8
11.740
285.000
34,7
12,8
0,90
27,1
17
18
28
0,92
0,67
0,36
0,31
-COV2 IgG
-COV2 IgM
21-11-22
Antigen
Positif
21-11-22
22-11-22

Penurunan kesadaran ec stroke
infark dd SOL
CAP
HHD
VES
Hiponatremia
Hipertensi
E4M6V3
107/55
92
20
100
7,425
31,9
168
20,9
22
-3
100
132
4,0
1,11
IVFD Nacl 3% 20cc/jam
Head Up 30
Resfar 1x2.5 gr IV
Ceftriaxone 1x2 gr IV
Vit C 3x400mg IV
Furosemide 2x20mg IV
Vit D 1x5000iu PO
Azitromicin 1x500mg PO
Bisoprolol 1x2.5mg PO
Amlodipin 1x5mg PO
9
10
11
12
DATE
BED 3 DAY OF CARE
IDENTITY
SEX LK
NAME Busmawardi DIAGNOSIS
AGE 72thn
MR 00877490 GCS
DATE IN 16-11-22 TD
VIT
DPJP AL HR
1. dr.Pratama Ananda, RR
SIG
M.Ked (Klin) Sp. An SPO2
N
2. TEMP
ANAMNESIS PH
PCO2
Pasien rujukan dari RSUD PO2
Petala Bumi datang dengan HCO3
keluhan sesak nafas yang AGD
TCO2
dialami os sejak 1 minggu ini
dan semakin memberat dalam BE
1 hari ini, nyeri dada(+), batuk SaO2
berdahak(+), demam(+), GDS
ELE Na
DIAGNOSIS CTR K
OLY Ca
Covid-19 terkonfirmas Derajat TE Lactat
Berat
OXYGEN
STEMI Anteroseptal
Sepsis INPUT
CAP OUTPUT
IWL
NOTES BALANCE
URINE
OUTPUT
(cc/kgbb/jam)
THERAPY
Fluid / Food
Analgetic
Sedation
Thromboemboli
cHead
prophylaxis
of bed
elevtation
Ulcer (stress)
prophylaxis
Glycemic
control
Spontaneous
Breathing Trial
Indwelling
Bowel Care
Catheter
Removal
De-escalation of
antibiotics
SUBJECTIVE
PHYSICAL EXAMI
PLANNING
NOTES
LABORATORIUM
Hemoglobin
Leukosit
Trombosit
Hematokrit
PT
INR
APTT
SGOT
SGPT
Ureum
Creatinin
Albumin
D-dimer
CRP
Ferritin
Anti HIV
HbsAg
Anti HCV
Total Bil
Bil Indirek
Bil Direk
IL-6
LDH
Anti SARS-COV2 IgG
Anti SARS-COV2 IgM
Urinalisa
Blood Culture
Urine Culture
Sputum Culture
Procalcitonin
Date
Swab
Result
Support
Date
16-11-22
Covid-19 terkonfirmas Derajat Berat

STEMI Anteroseptal
Sepsis
CAP
E4M6V5
90/73
116
28
100
36,5
7,40
44
128
27,4
29
3
99
138
3,8
HFNC 50 T34 Fio2 80%

IVFD RL 60cc/jam
Clopidogrel 1x75mg PO
Aspilet 1x80mg PO
Head Up 30'
Omeprazole 2x40mg IV
Resfar 1x5gr IV
Vit C 3x400mg IV
Remdesivir 1x100mg IV H3
Meropenem 3x1 gr IV
Furosemid 2x20mg IV
Vit D 1x5000iu PO
Curcuma 3x1 PO
Candesartan 1x16mg PO (tunda)
Atorvastatin 1x40mg PO
Nebule Combivent + Pulmicort /8jam
16-11-22
15,1
21.360
695.000
46,3
17,4
1,23
30,4
36
25
66,0
0,89
3,3
-COV2 IgG
-COV2 IgM
15-11-22
PCR
Positif
17-11-22

STEMI Anteroseptal
CAP
E4M6V5
130/107
129
30
100
36,6
7,48
41
73
30,8
32
7
96
135
3,1
1,18
HFNC 40 T34 FiO2 80%

17-11-22
14,1
16.530
679.000
42,4
24,5
1,77
35,5
83,0
0,75
2,6
117,7
16-11-22
PCR
Positif
18-19-22

STEMI Anteroseptal
CAP
E4M6V5
99/65
123
18
99
36,5
7,445
45,9
233
31,6
33
7
100
121
135
3,4
1,2

2640
1480
499,5
+290,5
1,3
IVFD RL 40cc/jam
DIVITI 1x2,5mg SC
Head Up 30'
Resfar 1x5gr IV
Vit C 3x400mg IV
Meropenem 3x1 gr IV
Furosemid 2x20mg IV
Vit D 1x5000iu PO
Curcuma 3x1 PO
ISDN 3x10mg
Capsul Garam 3x1
Nebule Combivent + Pulmicort
/8jam
18-11-22
65,8
529,3
20,31
1.2000
19-11-22
4
STEMI Anteroseptal
Sepsis
Hiponatremia
Hipokalemia
Hiperkoagulopati
E4M6V5
113/70
102
18
100
36,5
7,5
43,5
158
33
35
11
100
128
131
3,1
1,09

2460
950
450
+1060
0,7
IVFD RL 40cc/jam
DIVITI 1x2,5mg SC
Head Up 30'
Resfar 1x5gr IV
Vit C 3x400mg IV
Meropenem 3x1 gr IV
Furosemid 2x20mg IV
Vit D 1x5000iu PO
Curcuma 3x1 PO
ISDN 3x10mg
Capsul Garam 3x1
/8jam
19-11-22
20-11-22
5
STEMI Anteroseptal
Sepsis
CAP
HHD
PPOK
E4M6V5
120/81
98
20
100
36,6
7,585
37,1
74
35,2
36
13
97
155
130
2,9
0,96

1924,8
1860
450
-385,2
1,7
IVFD RL 40cc/jam
KCL 25mEq dalam NaCl 0,9%
100cc habis dalam 5 jam
DIVITI 1x2,5mg SC
Head Up 30'
Resfar 1x5gr IV
Vit C 3x400mg IV
Meropenem 3x1 gr IV
Furosemid 2x20mg IV
Vit D 1x5000iu PO
Curcuma 3x1 PO
ISDN 3x10mg
Capsul Garam 3x1
/8jam
20-11-22
10,7
13.430
443.000
32,5
17,5
1,24
32
18
28
92
0,59
2,2
21-11-22
6
STEMI Anteroseptal
Sepsis
CAP
HHD
PPOK
E4M6V5
87/63
78
11
100
36,5
7,5
56,2
233
44,4
46
21
100
135
2,9
1,12

1924,8
1860
450
-385,2
1,7
IVFD RL 40cc/jam
DIVITI 1x2,5mg SC
Head Up 30'
Resfar 1x5gr IV
Vit C 3x400mg IV
Meropenem 3x1 gr IV
Furosemid 2x20mg IV
Vit D 1x5000iu PO
Curcuma 3x1 PO
ISDN 3x10mg
Capsul Garam 3x1
/8jam
22-11-22
7
STEMI Anteroseptal
Sepsis
CAP
HHD
PPOK
E4M6V5
123,75
102
23
97
36,6
7,507
48,1
76
38,1
40
15
96
139
3,5
1,17
NC 6LPM
IVFD RL 40cc/jam
DIVITI 1x2,5mg SC
Head Up 30'
Resfar 1x5gr IV
Vit C 3x400mg IV
Meropenem 3x1 gr IV
Furosemid 2x20mg IV
Vit D 1x5000iu PO
Curcuma 3x1 PO
ISDN 3x10mg
Capsul Garam 3x1
/8jam
9
10
11
12
DATE
BED 5 DAY OF CARE
IDENTITY
SEX LK
NAME Jasmadi DIAGNOSIS
AGE 53thn
MR 01109726 GCS
DATE IN 18-11-22 TD
VIT
DPJP AL HR
1. dr.Novita RR
SIG
Anggraeni,sp.An,KIC,M.Kes N SPO2
2. TEMP
ANAMNESIS PH
PCO2
Sesak nafas sejak 5 hari,
batuk(+) demam (+), pasien PO2
sudah dirawat 2 hari di ruangan AGD HCO3
isolasi TCO2
RPD : riwayat tumor paru BE
kanan rencana dilakukan SaO2
bronkoskopi tapi hasil swab GDS
positif Na
ELE
DIAGNOSIS CTR K
OLY Ca
COVID-19 terkonfirmasi TE Lactat
derajat berat
OXYGEN
Atelektasis paru kanan
Tumor paru kanan INPUT
Gagal nafas tipe I OUTPUT
IWL
NOTES BALANCE
URINE
OUTPUT
(cc/kgbb/jam)
THERAPY
Fluid / Food
Analgetic
Sedation
Thromboemboli
cHead
prophylaxis
of bed
elevtation
Ulcer (stress)
prophylaxis
Glycemic
control
Spontaneous
Breathing Trial
Indwelling
Bowel Care
Catheter
Removal
De-escalation of
antibiotics
SUBJECTIVE
PHYSICAL EXAMI
PLANNING
NOTES
LABORATORIUM
Hemoglobin
Leukosit
Trombosit
Hematokrit
PT
INR
APTT
SGOT
SGPT
Ureum
Creatinin
Albumin
D-dimer
CRP
Ferritin
Anti HIV
HbsAg
Anti HCV
Total Bil
Bil Indirek
Bil Direk
IL-6
LDH
Anti SARS-COV2 IgG
Anti SARS-COV2 IgM
Urinalisa
Blood Culture
Urine Culture
Sputum Culture
Procalcitonin
Date
Swab
Result
Support
Date
18-11-22
COVID-19 terkonfirmasi derajat berat

Tumor paru kanan
Gagal nafas tipe I
E4M6V5
115/73
88
28
100
7,492
29,1
60
22,2
23
-1
93
132
4,1
1,15
NRM 15LPM
IVFD RL 20cc/jam
Head Up 30
Remdesivir 1x100mg IV
Resfar 1x2.5 gr IV
Asam Tranexamat 3x500mg IV
Deksamethasone 1x5mg IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
18-11-22
13,3
9.300
368.000
44,4
15,4
1,12
33,6
46
41
17
0,79
2,9
1,98
-COV2 IgG
-COV2 IgM
16-11-22
PCR
Positif
19-11-22
2
COVID-19 terkonfirmasi derajat
berat
Tumor paru kanan
Gagal nafas tipe I
E4M6V5
103/74
71
27
96
7,44
35,6
114
24,5
26
0
99
129
3,5
1,09
NRM 15LPM
1130
750
329,1
+50,9
1,2
IVFD NaCl 3% 20cc/jam
IVFD NaCl 0,9% 40cc/jam
Head Up 30
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
19-11-22
0,41
0,17
0,24
19-11-22
20-11-22
3
berat
Tumor paru kanan
Gagal nafas tipe I
E4M6V5
92/71
97
21
98
36,5
7,44
36,1
67
24,7
26
1
94
137
3,7
1,17
NRM 15LPM
3640
3950
610
-920
2,6
IVFD RL 60cc/jam
Head Up 30
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
Nebu Combivent + Pulmicort/8
jam
21-11-22
4
berat
Tumor paru kanan
Gagal nafas tipe I
E4M6V5
102/67
64
25
100
36,6
7,438
39,6
77
26,8
28
3
96
139
3,8
1,19
NRM 15LPM
3940
3950
610
-620
2,6
IVFD RL 60cc/jam
Head Up 30
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
jam
21-11-22
15,1
16.25
460
49,9
15,3
1,08
31,0
21,0
0,61
2,5
1,45
0,26
0,09
0,17
22-11-22

berat
Tumor paru kanan
Gagal nafas tipe I
E4M6V5
111/81
70
22
95
36,5
IVFD RL 60cc/jam
Head Up 30
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
jam
9
10
11
12
DATE
BED 6 DAY OF CARE
IDENTITY
SEX PR
NAME Legiyem DIAGNOSIS
AGE 72thn
MR 01112437 GCS
DATE IN 17-11-22 TD
VIT
DPJP AL HR
1. dr.T. Addi, Sp. An RR
SIG
2. SPO2
N
TEMP
ANAMNESIS PH
PCO2
Penurunan kesadaran dialami PO2
sejak 2 hari yang lalu, AGD HCO3
demam(+) batuk berdahak(+), TCO2
sesak nafas(+), mual (-) BE
muntah(-) , os riwayat Storke SaO2
2017 GDS
ELE Na
DIAGNOSIS CTR K
Suspect Covid-19 Derajat OLY Ca
Berat TE Lactat
Penurunan Kesadaran ec? OXYGEN
Sequele Stroke dd SNH INPUT
Hiperkoagulopati OUTPUT
Impending Gagal Nafas IWL
NOTES BALANCE
URINE
OUTPUT
(cc/kgbb/jam)
THERAPY
Fluid / Food
Analgetic
Sedation
Thromboemboli
cHead
prophylaxis
of bed
elevtation
Ulcer (stress)
prophylaxis
Glycemic
control
Spontaneous
Breathing Trial
Indwelling
Bowel Care
Catheter
Removal
De-escalation of
antibiotics
SUBJECTIVE
PHYSICAL EXAMI
PLANNING
NOTES
LABORATORIUM
Hemoglobin
Leukosit
Trombosit
Hematokrit
PT
INR
APTT
SGOT
SGPT
Ureum
Creatinin
Albumin
D-dimer
CRP
Ferritin
Anti HIV
HbsAg
Anti HCV
Total Bil
Bil Indirek
Bil Direk
IL-6
LDH
Anti SARS-COV2 IgG
Anti SARS-COV2 IgM
Urinalisa
Blood Culture
Urine Culture
Sputum Culture
Procalcitonin
HBA1c
Date
Swab
Result
Support
Date
17-11-22
Suspect Covid-19 Derajat Berat

Penurunan Kesadaran ec?
Sequele Stroke dd SNH
Hiperkoagulopati
Impending Gagal Nafas
E2M5V2
133/91
92
18
99
7,48
39
185
30
31
7
100
150
3,4
112
NRM 10LPM
IVFD RL 60cc/jam
Lovenox 2x0,4cc
Head Up 30'
Omeprazole 2x40mg
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
17-11-22
15,9
11.410
144.000
49,3
12,6
0,88
26,0
19
2
71,0
0,55
3,5
11,64
123,7
1,32
0,65
0,67
133,10
-COV2 IgG
-COV2 IgM
16-11-22
Antigen
Negatif
18-11-22
2
Covid-19 Derajat Berat
Hiperkoagulopati
Impending Gagal Nafas
E3M3V2
130/83
100
18
99
7,495
41,5
183
32
33
9
100
137
2,7
1,09
NRM 10LPM
2006
1000
514
+492
0,6
IVFD RL 60cc/jam
Lovenox 2x0,4cc
Head Up 30'
Omeprazole 2x40mg
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
18-11-22
5,2
17-11-22
PCR
Positif
19-11-22
3
Hiperkoagulopati
Gagal Nafas Tipe 1
Hipokalemia (Perbaikan)
E1M3Vafasia
120/74
130
32
95
7,46
38,1
51
27,2
28
3
86
136
3,3
1,09
HFNC Flow 60 T34 FiO2 90%

2575,9
300
648,8
+1627,1
0,3
IVFD RL 60cc/jam
Lovenox 2x0,4cc
Aspilet 1x80mg
Head Up 30'
Omeprazole 2x40mg
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Citikolin 2x500mg IV
Vit D 1x5000iu PO
20-11-22
4
Hiperkoagulopati
Gagal Nafas Tipe 1
E1M3Vafasia
120/74
130
32
95
7,470
40,5
76
29,5
31
6
95
136
3,3
1,09
HFNC Flow 60 T34 FiO2 90%

2060
1530
648,8
-118,1
0,98
IVFD RL 60cc/jam
Lovenox 2x0,4cc
Aspilet 1x80mg
Head Up 30'
Omeprazole 2x40mg
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
Atorvastatin 1x20mg
20-11-22
13,2
13.58
158
39,4
19,4
1,39
50,1
24
7
45
0,42
2,3
20-11-22
21-11-22
5
Hiperkoagulopati
Gagal Nafas Tipe 1
E2M3V4
128/71
110
32
98
7,56
37,7
68
34,3
35
12
96
200
141
2,4
1,05
HFNC Flow 60 T34 FiO2 90% + NRM 15LPM

2060
1530
6500
-118,1
63,75
IVFD RL 60cc/jam
Lovenox 2x0,4cc
Aspilet 1x80mg
Head Up 30'
Omeprazole 2x40mg
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
Atorvastatin 1x20mg
22-11-22
6
Hiperkoagulopati
Gagal Nafas Tipe 1
E3M4Vaff
123/67
112
22
100
7,513
45,9
203
36,9
38
14
100
114
146
2,4
1,07
HFNC Flow 80 T34 FiO2 95% + NRM 15LPM

IVFD RL 60cc/jam
Lovenox 2x0,4cc
Aspilet 1x80mg
Head Up 30'
Omeprazole 2x40mg
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
Atorvastatin 1x20mg
RM 15LPM
9
10
11
12
DATE
BED 8 DAY OF CARE
IDENTITY
SEX PR
NAME Lamiyem
DIAGNOSIS
56thn
AGE
MR 01112540 GCS
DATE IN TD
VIT
DPJP AL HR
1. dr.T. Addi, Sp. An RR
SIG
2. SPO2
N
Sesak napas memberat sejak TEMP
ANAMNESIS
tadi pagi, nyeri dada seperti PH
PCO2
terhimpit. Pasien baru seledai
rawatan 1 hari dari RS luar lalu PO2
disaran, di diagnosa AGD HCO3
paraparesis ec severe TCO2
neuropati dll, pasien sudah ke 3 BE
alinya sernagan infark. SaO2
Kelemaham pada seluruh GDS
anggota gerak sejak 2 minggu Na
ini. Pasien sebelumnya sudah ELE
DIAGNOSIS CTR K
3x serangan stroke.
berat
HAP OLY Ca
Tetraparese ec Stroke infark TE Lactat
Tetraparese ec Stroke infark
dd severe neuropati OXYGEN
ALO INPUT
Aki dd acute on CKD OUTPUT
Dm tipe 2
IWL
Hipertensi
NOTES BALANCE
URINE
OUTPUT
(cc/kgbb/jam)
THERAPY
Fluid / Food
Analgetic
Sedation
Thromboemboli
cHead
prophylaxis
of bed
elevtation
Ulcer (stress)
prophylaxis
Glycemic
control
Spontaneous
Breathing Trial
Indwelling
Bowel Care
Catheter
Removal
De-escalation of
antibiotics
SUBJECTIVE
PHYSICAL EXAMI
PLANNING
NOTES
LABORATORIUM
Hemoglobin
Leukosit
Trombosit
Hematokrit
PT
INR
APTT
SGOT
SGPT
Ureum
Creatinin
Albumin
D-dimer
CRP
Ferritin
Anti HIV
HbsAg
Anti HCV
Total Bil
Bil Indirek
Bil Direk
IL-6
LDH
Anti SARS-COV2 IgG
Anti SARS-COV2 IgM
Urinalisa
Blood Culture
Urine Culture
Sputum Culture
Procalcitonin
Date
Swab
Result
Support
Date
18-11-22
1
Covid terkonfirmasi derajat berat

HAP
Tetraparese ec Stroke infark dd severe
neuropati
ALO
Aki dd acute on CKD
Dm tipe 2
Hipertensi
Hiperkalemia (post koreksi)
E4M6V5
115/61
105
14
99
36,5
7,434
37,5
174
25,1
26
1
100
138
6,2
1,17
HFNC Flow 40 T34 Fio2 80%
Paracetamol 3x1 gr IV
Diviti 1x2.5 mg SC
Head Up 30'
Novorapid 12-12-12
Resfar 1x2.5 gr IV
Moxifloxacin 1x400mg IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
Amlodipin 1x10mg PO
18-11-22
11,4
12.390
383.000
34,5
12,4
23,9
27
25
187
1,1
2,94
17,3
1.021,01
-COV2 IgG
-COV2 IgM
18-11-22
Antigen
Positif
17-11-22
19-11-22

HAP
Tetraparese ec Stroke infark dd
severe neuropati
ALO
Aki dd acute on CKD
Dm tipe 2
Hipertensi
Hiperkalemia (post koreksi)
E4M6V5
130/74
90
10
99
36,6
7,34
49,1
177
26,5
28
1
99
300
142
5,1
1,18
1231,2
1700
533,3
-1002,1
1,5
Diviti 1x2.5 mg SC
Head Up 30'
Novorapid 12-12-12
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
Amlodipin 1x10mg PO
19-11-22
227,0
1,43
0,43
0,16
0,27
4,25
18-11-22
PCR
Positif
20-11-22

HAP
severe neuropati
ALO
Aki dd acute on CKD
Dm tipe 2
Hipertensi
E4M6V5
142/76
112
15
96
36,5
7,32
55,8
77
28,9
31
3
94
149
5,1
1,19
1323,9
2600
533,3
-1809,4
1,3
Diviti 1x2.5 mg SC
Head Up 30'
Novorapid 12-12-12
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
Amlodipin 1x10mg PO
Favirapir 2x1600
Nebu Combivent /8jam
21-11-22

HAP
severe neuropati
ALO
Aki dd acute on CKD
Dm tipe 2
Hipertensi
E4M6V5
130/68
108
16
100
36,4
7,334
53,6
130
28,5
30
3
99
155
4,9
1,31
1383,9
2600
533,3
-1809,9
1,3
Diviti 1x2.5 mg SC
Head Up 30'
Novorapid 12-12-12
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
Amlodipin 1x10mg PO
Favirapir 2x1600
21-11-22
10,6
18.110
250.000
35,7
14,9
1,05
27,6
1,13
22-11-22

HAP
severe neuropati
ALO
Aki dd acute on CKD
Dm tipe 2
Hipertensi
E4M6V5
116/58
78
14
100
36,5
7,330
60,7
117
32,0
34
6
98
151
4,6
1,24
Diviti 1x2.5 mg SC
Head Up 30'
Novorapid 12-12-12
Resfar 1x2.5 gr IV
Vit C 3x400mg IV
Vit D 1x5000iu PO
Amlodipin 1x10mg PO
Favirapir 2x1600
9
10
11
12
DATE
BED DAY OF CARE
IDENTITY
SEX
NAME DIAGNOSIS
AGE
MR GCS
DATE IN TD
DPJP HR
VITAL
1. dr.Novita Anggraeni,sp.An,KIC,M.Kes RR
SIGN
2. SPO2
TEMP
ANAMNESIS PH
PCO2
PO2
AGD HCO3
TCO2
BE
SaO2
GDS
Na
DIAGNOSIS ELECT K
ROLY
TE Ca
Lactat
OXYGEN
INPUT
OUTPUT
IWL
NOTES BALANCE
URINE OUTPUT
(cc/kgbb/jam)
THERAPY
Fluid / Food
Analgetic
Sedation
Thromboembolic
prophylaxis
Head of bed elevtation
Ulcer (stress)
prophylaxis
Glycemic control
Spontaneous Breathing
Trial
Bowel Care
Indwelling Catheter
Removal
De-escalation of
antibiotics
SUBJECTIVE
PHYSICAL EXAMINATION
PLANNING
NOTES
LABORATORIUM
Hemoglobin
Leukosit
Trombosit
Hematokrit
PT
INR
APTT
SGOT
SGPT
Ureum
Creatinin
Albumin
D-dimer
CRP
Ferritin
Anti HIV
HbsAg
Anti HCV
Total Bil
Bil Indirek
Bil Direk
IL-6
LDH
Anti SARS-COV2 IgG
Anti SARS-COV2 IgM
Urinalisa
Blood Culture
Urine Culture
Sputum Culture
Procalcitonin
Date
Swab
Result
Support
Date
9
10
11
12

22-11-22 Ricu

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

22-11-22 Ricu

Uploaded by

Copyright:

Available Formats

DATE

BED 1 DAY OF CARE

Susp.COVID-19 Derajat Berat

IVFD Nacl 0.9% 40cc/jam

Susp.COVID-19 Derajat Berat

Covid-19 terkonfirmas Derajat Berat

HFNC 50 T34 Fio2 80%

Covid-19 terkonfirmas Derajat Berat

HFNC 40 T34 FiO2 80%

Covid-19 terkonfirmas Derajat Berat

HFNC 40 T34 FiO2 60%

HFNC 40 T34 FiO2 60%

HFNC 40 T34 FiO2 60%

HFNC 50 T34 FiO2 70%

COVID-19 terkonfirmasi derajat berat

COVID-19 terkonfirmasi derajat

Suspect Covid-19 Derajat Berat

HFNC Flow 60 T34 FiO2 90%

HFNC Flow 60 T34 FiO2 90%

HFNC Flow 60 T34 FiO2 90% + NRM 15LPM

HFNC Flow 80 T34 FiO2 95% + NRM 15LPM

Covid terkonfirmasi derajat berat

IVFD Nacl 0.9% 20cc/jam

Covid terkonfirmasi derajat berat

IVFD Nacl 0.9% 20cc/jam

Covid terkonfirmasi derajat berat

IVFD Nacl 0.9% 20cc/jam

Covid terkonfirmasi derajat berat

IVFD Nacl 0.9% 20cc/jam

Covid terkonfirmasi derajat berat

You might also like